Titlebook: Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis; Albert V. G. Bruschke,Johan H. C. Reiber,Hein J. J Book 1996 Kluwer Ac

只看該作者 · 發(fā)表于 2025-3-29 01:46:52

The St Thomas’ Atherosclerosis Regression Study and an appraisal of its potential limitationsoint blinded study of the effects of lipid-lowering therapy on angiographic coronary artery disease (CAD) in male patients with hypercholesterolemia. Both a fat-modified diet and diet-plus cholestyramine favourably influenced the course of CAD over 3 years. As discussed in this paper, the study did,

只看該作者 · 發(fā)表于 2025-3-29 03:08:16

只看該作者 · 發(fā)表于 2025-3-29 09:25:01

只看該作者 · 發(fā)表于 2025-3-29 11:54:39

Impact upon angiographic disease progression following step drug therapy in normolipidaemic patients potential benefit of drug therapy in normocholesterolaemic patients has not been examined in a randomized prospective fashion. Patients with symptomatic coronary artery disease with at least one lesion narrowed by >30% were randomized to either placebo (. = 39), or stepped drug therapy using pravas

只看該作者 · 發(fā)表于 2025-3-29 17:17:56

L. Campeau,J. Lespérance,D. Waters,CCAIT Investigators

只看該作者 · 發(fā)表于 2025-3-29 19:52:51

只看該作者 · 發(fā)表于 2025-3-30 01:49:58

只看該作者 · 發(fā)表于 2025-3-30 04:24:37

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 07:48
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved